Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27692623)
Watch
English
Primary systemic chemotherapy for inflammatory breast cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
1 reference
stated in
Europe PubMed Central
title
Primary systemic chemotherapy for inflammatory breast cancer
(English)
1 reference
stated in
PubMed
main subject
chemotherapy
0 references
inflammatory breast cancer
1 reference
based on heuristic
inferred from title
author name string
Sarah Sinclair
series ordinal
1
1 reference
stated in
Crossref
Sandra M. Swain
series ordinal
2
1 reference
stated in
Crossref
language of work or name
English
0 references
publication date
1 June 2010
1 reference
stated in
PubMed
published in
Cancer
1 reference
stated in
PubMed
volume
116
1 reference
stated in
PubMed
issue
11 Suppl
1 reference
stated in
PubMed
page(s)
2821-8
1 reference
stated in
PubMed
cites work
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Surgical aspects of inflammatory breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ten-year outcome after combined modality therapy for inflammatory breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy for inflammatory breast cancer: impact of doxorubicin-based therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of inflammatory breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High incidence of HER-2 positivity in inflammatory breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Angiogenesis in cancer, vascular, rheumatoid and other disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pazopanib: a novel multitargeted tyrosine kinase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p53 expression as a prognostic marker in inflammatory breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term results of combined-modality therapy for inflammatory breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.25166
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.25166
0 references
PubMed publication ID
20503414
1 reference
stated in
PubMed
ResearchGate publication ID
44631183
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
